MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

NeoGenomics Inc

Slēgts

10.05 1.72

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

9.7

Max

10.13

Galvenie mērījumi

By Trading Economics

Ienākumi

2.4M

-15M

Pārdošana

4.2M

172M

EPS

0.04

Peļņas marža

-8.909

Darbinieki

2,200

EBITDA

1.9M

3.7M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+66.3% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 29. apr.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-360M

1.2B

Iepriekšējā atvēršanas cena

8.33

Iepriekšējā slēgšanas cena

10.05

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

NeoGenomics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 23. apr. 15:50 UTC

Iegādes, apvienošanās, pārņemšana

Cantor Agrees to $3.6 Billion SPAC Deal With Crypto Company Twenty One -- Update

2025. g. 23. apr. 14:29 UTC

Iegādes, apvienošanās, pārņemšana

Cantor Agrees to $3.6 Billion SPAC Deal With Crypto Company Twenty One

2025. g. 16. apr. 15:17 UTC

Galvenie tirgus virzītāji

Janover Shares Drop After Partnership Plans With Crypto Exchange

2025. g. 10. apr. 15:12 UTC

Galvenie tirgus virzītāji

Janover Shares Rise After Company Begins Solana Purchases

2025. g. 24. apr. 11:49 UTC

Tirgus saruna

Bitcoin Eases After Recent Risk-On Rally -- Market Talk

2025. g. 23. apr. 15:35 UTC

Iegādes, apvienošanās, pārņemšana

Cantor Agrees to $3.6B SPAC Deal With Crypto Company Twenty One -- Update

2025. g. 23. apr. 14:14 UTC

Iegādes, apvienošanās, pārņemšana

Cantor Agrees to $3.6B SPAC Deal With Crypto Company Twenty One

2025. g. 23. apr. 09:17 UTC

Top Ziņas

Bitcoin Price Rises Above $94,000 -- WSJ

2025. g. 23. apr. 09:04 UTC

Top Ziņas

Bitcoin Price Rallies. Why Trump, Fed and China Are Boosting the Crypto. -- Barrons.com

2025. g. 23. apr. 08:37 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 23. apr. 08:37 UTC

Tirgus saruna

Bitcoin Rises on Hopes For De-Escalation in U.S.-China Trade War -- Market Talk

2025. g. 23. apr. 01:00 UTC

Top Ziņas

'I Could Lose It All Tomorrow': The Traders Leaning In to Wild Markets -- WSJ

2025. g. 22. apr. 13:58 UTC

Tirgus saruna

Fed Independence Concerns Could Lift Bitcoin to Record High -- Market Talk

2025. g. 22. apr. 08:47 UTC

Tirgus saruna

Bitcoin Rises as Investors Seek Dollar Alternatives -- Market Talk

2025. g. 21. apr. 14:28 UTC

Top Ziņas

Bitcoin Rises. Tariffs, the Dollar, and What Else Is Boosting Crypto Prices. -- Barrons.com

2025. g. 21. apr. 14:01 UTC

Iegādes, apvienošanās, pārņemšana

MicroStrategy Stock Is Rising on Latest $556 Million Bitcoin Purchase -- Barrons.com

2025. g. 21. apr. 09:30 UTC

Top Ziņas

Crypto Knocks on the Door of a Banking World That Shut It Out -- WSJ

2025. g. 21. apr. 09:04 UTC

Top Ziņas

Bitcoin and Other Crypto Prices Rise. It's All Linked to Dollar Weakness. -- Barrons.com

2025. g. 17. apr. 14:03 UTC

Tirgus saruna

ECB's Lagarde Welcomes Review of Stablecoin Regulation -- Market Talk

2025. g. 17. apr. 14:01 UTC

Tirgus saruna

ECB's Lagarde Highlights Digital Euro Efforts -- Market Talk

2025. g. 17. apr. 09:48 UTC

Tirgus saruna

Bitcoin Struggles to Rise Meaningfully After Trade News, Powell Remarks -- Market Talk

2025. g. 16. apr. 16:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 16. apr. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 16. apr. 16:09 UTC

Tirgus saruna

Crypto Trading Demand Lower Than Expected, Interactive Brokers CEO Says -- Market Talk

2025. g. 15. apr. 08:33 UTC

Tirgus saruna

Bitcoin Edges Higher Amid Optimism Over Tariff Exemptions -- Market Talk

2025. g. 14. apr. 15:52 UTC

Iegādes, apvienošanās, pārņemšana

MicroStrategy Stock Rises. It Expands Bitcoin Holdings With $286 Million Purchase. -- Barrons.com

2025. g. 14. apr. 14:10 UTC

Iegādes, apvienošanās, pārņemšana

MicroStrategy Stock Rises. It Expands Bitcoin Holdings With $286 Million Purchase. -- Barrons.com

2025. g. 14. apr. 08:41 UTC

Top Ziņas

Bitcoin, XRP, Ether Prices Mixed Amid Tariff Turmoil. Watch This Key Crypto Level. -- Barrons.com

2025. g. 10. apr. 11:37 UTC

Tirgus saruna

Bitcoin Falls After Brief Boost From Tariff Delay -- Market Talk

2025. g. 9. apr. 10:51 UTC

Tirgus saruna

Bitcoin Struggles to Recover Meaningfully as Tariff Worries Cap Gains -- Market Talk

Salīdzinājums

Cenas izmaiņa

NeoGenomics Inc Prognoze

Cenas mērķis

By TipRanks

66.3% augšup

Prognoze 12 mēnešiem

Vidējais 16.78 USD  66.3%

Augstākais 19 USD

Zemākais 12 USD

Pamatojoties uz 14 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

14 ratings

10

Pirkt

4

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

9.56 / 10.44Atbalsts un pretestība

Īstermiņā

Weak Bullish Evidence

Vidējā termiņā

Weak Bullish Evidence

Ilgtermiņā

Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.